Frequently, liver masses are found in the course of medical imaging examinations. This article presents a unique case study with multiple benign liver masses: hemangiomas, focal nodular hyperplasias (FNHs), and liver cell adenomas (LCAs). Most hemangiomas have a characteristic echogenic appearance on sonography and need no further workup. FNH may be difficult to visualize sonographically because it is composed of normal hepatocytes in an abnormal arrangement. LCAs and liver adenomatosis are more serious, requiring medical intervention and monitoring.
With increased medical imaging, the discovery of incidental solid liver lesions ("incidentalomas") has risen. 1 Sonographers routinely discover hepatic hemangiomas when performing abdominal studies. Their characteristic echogenic, homogeneous, well-circumscribed appearance is well known and no cause for alarm. About 4% of the population has hemangiomas. 2 Second in frequency are focal nodular hyperplasias (FNHs). FNH is not a true neoplasm but an overgrowth of hepatocytes in response to an abnormal blood supply. FNH appears sonographically isoechoic to the liver parenchyma and is identified by a bulged contour or an increased blood supply. Hemangiomas and FNH present no danger to the patient; therefore, further testing and monitoring are not necessary once a diagnosis has been made. The third type of "incidentalomas," liver cell adenomas (LCAs), are rare and pose a health risk because they tend to hemorrhage and may evolve into hepatocellular carcinoma. For this reason, they require treatment by liver resection or monitoring. Liver adenomatosis (LA) is a condition in which multiple LCAs are present in the liver. LA occurs in 10% to 24% of patients with LCA and is classified as a separate disorder because of a differing etiology. 3 This article summarizes a rare case with multiple liver hemangiomas, FNHs, and LCAs followed by a discussion of these benign liver lesions and LA.
Case Study
An asymptomatic woman in her mid-50s had an incidental finding of innumerable solid liver tumors by sonography. Her history was significant for alloimmune thrombocytopenia onset during adolescence, splenectomy, previous limited use of oral contraceptives, hysterectomy, and bilateral oophorectomy with subsequent use of estrogen hormone replacement for a number of years and long-term use of serotonin uptake inhibitors. Her mother died in her mid-50s from cholangiocarcinoma.
A right upper quadrant sonogram, abdominal computed tomography (CT) scan, liver magnetic resonance imaging (MRI) scan, CT-guided percutaneous liver biopsy of the two most inferior right lobe lesions, and laboratory tests were performed to diagnose the liver lesions.
Sonography showed a well-defined 2-cm echogenic nodule characteristic of a hemangioma in the right lobe. In the most inferior aspect of the right lobe, two coalescing isoechoic nodules were identified because they distorted the usual contour. Other echogenic nodules were also noted. CT identified the hemangioma and differentiated between the two inferior FNHs (2 and 3 cm) and multiple LCAs. The two largest LCAs were 3.2 and 3.5 cm. The CT report could not exclude malignancy. A dynamic MRI was performed. Two hemangiomas, two FNHs, and innumerable LCAs were identified by MRI. The largest two LCAs measured 3.3 cm. They appeared to contain foci on intracellular lipids and showed increased flow in the arterial phase. The two inferior right 407197J DM27310.1177/8756479311407197Bo odtJournal of Diagnostic Medical Sonography 1 Holland Community Hospital, Holland, MI, USA lobe nodules were biopsied. Both were confirmed to be FNH and described as fibrous bands with mild ductular proliferation, large abnormal arteries, and normal hepatocytes. Liver panel values were consistently in the normal range with slightly elevated alpha fetal protein (AFP) measuring 6 to 8 ng/mL (normal range, 0-6 ng/mL). The patient is being followed with biannual liver function tests and AFP as well as annual MRI. Sonography with fusion to MRI (GE Logiq E9, Milwaukee, Wisconsin) was attempted to correlate the MRI findings with sonography. In two years of follow-up, the laboratory values and imaging studies have shown no significant change, and the patient remains asymptomatic.
Discussion Hemangiomas
Our case has two hemangiomas in the right lobe: one 2 cm and a second 8 mm (Figures 1 and 2 ). Hemangiomas occur in multiples 10% to 33% of the time and are more common in the right lobe of the liver. 1 They occur three to six times more frequently in women than in men. 1, 4 Cavernous hemangiomas are generally less than 5 cm in size, but sizes range from millimeters to 20 cm. 1 Giant hemangiomas, which are classified as greater than 5 cm, can cause problems because of compression on surrounding structures. Likely symptoms of giant hemangiomas are right upper quadrant pain, nausea, vomiting, and early satiety. Rarely obstructive jaundice, gastric outlet obstruction, hemobilia, inferior vena cava compression, portal hypertension, disseminated intravascular coagulation, and localized thrombosis may occur. Hemangiomas are large vascular spaces lined with epithelium and separated by fibrous septae. 4 They enlarge by ectasia, not cellular multiplication.
Definitive diagnosis is made by imaging, specifically CT or MRI, because they can demonstrate a unique blood flow pattern. Blood fills the periphery of the hemangioma and slowly fills to the center. Because of the vascular nature of hemangiomas, biopsy is discouraged. Generally, they are not biopsied because of bleeding risks, but some atypical hemangiomas have been biopsied with success. 5 Sonography is usually the modality that discovers hemangiomas because it is often the first imaging modality ordered for right upper quadrant pain, elevated liver enzymes, and other abdominal concerns. Often typicalappearing hemangiomas found incidentally by sonography will require little investigation in a patient without history of liver disease or malignancy. Typically, they are less than 5 cm; are hyperechoic with sharp, well-defined margins; and have posterior enhancement; little or no flow is demonstrated with color Doppler because of the slow blood velocity within them. They do not have the hypoechoic halo often seen with malignancies, although a hypoechoic center may be seen. When a hemangioma needs a definitive diagnosis, it may be followed by sonography at intervals to check for changes, or contrastenhanced CT or MRI may be performed to demonstrate the classic blood flow pattern of hemangiomas. Giant hemangiomas, hemangiomas larger than 5 cm, vary in sonographic appearance, presenting as heterogeneous, hypoechoic, or isoechoic, so they are more likely to be biopsied because of their uncharacteristic appearance. 5 Currently in the United States, sonography cannot definitively demonstrate the classic blood flow pattern of hemangiomas because Food and Drug Administration (FDA) approval for abdominal sonography contrast has not yet occurred. In Europe, studies have been done to compare the sensitivity and specificity of contrastenhanced ultrasound (CEUS) using SonoVue (Bracco, Milan, Italy) to CT and MRI. SonoVue is a microbubble contrast agent that enables sonography to display the blood flow characteristics of liver nodules. CEUS displays the blood flow in a lesion in real time, whereas CT and MRI only show it at timed intervals. Contrastenhanced sonography examinations are less toxic and cost less than CT and MRI contrast examinations. In addition, sonographic equipment is more portable, less costly, and plentiful. A European study found that CEUS correctly diagnosed 59 of 67 benign liver tumors. This surpassed the 50 of 67 correctly diagnosed by CT/MRI. The authors concluded that CEUS should be the first-line imaging modality for diagnosis of solid liver tumors. If CEUS were used in the United States, sonography could be the definitive study to identify hemangiomas without the further need of additional and more expensive modalities. 6 
Focal Nodular Hyperplasia
FNHs, like hemangiomas, are caused by vascular malformations, and both are frequently found in the same liver. They occur more often in women than in men and are often found during the reproductive years. Therefore, estrogen may play a role in the formation of FNH, but it has not been proven. FNH is the second most common solid liver tumor and occurs in 1%-3% to 2.5%-8% of the population. 1, 5 Usually FNH is a solitary lesion, but multiples such as in the case presented here have been seen. Most are 3 to 5 cm in size, but some as large as 19 cm have been found. 1 FNH is considered an overgrowth of hepatocytes responding to a vascular malformation. Thus, they are better classified as hyperplasias rather than masses. FNHs are fed by hepatic arteries and drain into hepatic veins. An aberrant vessel carries blood from the hepatic artery to the center of the FNH and is then carried by spokewheel-like arteries to the periphery of the lesion. The feeding artery is larger than would be expected for that area of the liver. 2 Microscopically, FNH consists of normal hepatocytes, Kupffer cells, biliary tracts, and components of portal triads. Normal hepatocytes are arranged abnormally, separated into nodules by fibrous septae often in a classic stellate configuration. 2, 7 With very few exceptions, FNH is an incidental finding on sonography. The classic appearance is an isoechoic vascular lesion with spoke-wheel blood vessels and a central scar (Figures 3, 4 , and 5), but a central scar is only found in 20% to 62% of FNHs. 1, 7 Because FNH is composed of normal hepatocytes, FNH is isoechoic to normal liver parenchyma, which makes it hard to distinguish with sonography. A bulging liver contour or an aberrant blood flow pattern (spoke-wheel) is the best way for a sonographer to locate an FNH. In this case study, the FNHs in the inferior liver were identified by the bulging contour and isoechoic. In some cases, FNHs may appear hypoechoic or echogenic. 2 CEUS accurately identifies FNH. Because it is supplied by a feeding arterial branch of the hepatic artery, a tortuous artery is seen entering the FNH, and the "spokewheel" vessels enhance. The FNH enhances rapidly equal to or greater than the adjacent parenchyma during the arterial phase. During the portal phase, the lesion continues to be hyper-or isoenhanced, and the central scar without blood flow can be seen. 2 Contrast-enhanced sonography is accurate enough to negate the need for further imaging. Rarely is biopsy necessary to make a diagnosis. Medical imaging, including CT and MRI, currently correctly identifies 70% of FNHs. 8 Because FNH is well supplied with blood, FNH is unlikely to necrose, calcify, or bleed. No follow-up is usually indicated once the diagnosis has been made. Rarely, one may calcify or cause symptoms because of large size.
FNH exists in two forms. The classical form accounts for 80% of FNHs, with the telangiectatic form accounting for the remaining 20%. The telangiectatic form has sinusoids fed by the arteries, has fewer fibrous septations, and lacks the central scar. The sinusoids are also features of peliotic LCAs. Telangiectatic FNH is more difficult to differentiate from LCAs and hepatocellular carcinomas (HCCs) by imaging. Telangiectatic FNHs are more common in men, vary in size from 2 to 19 cm, are more likely to be multiple, and may have atypia in the cells. 4 Some think telangiectatic FNH is more accurately classified as peliotic LCA. 9 Also, FNH sometimes coexists with liver cell adenomas as in this case study.
Liver Cell Adenomas
LCAs were first identified in 1958 by Edmondson as encapsulated liver tumors without bile ducts. 14 He discovered two in a series of 50,000 autopsies. Of the three most common solid benign liver tumors, LCAs are fortunately the rarest because, unlike hemangiomas and FNH, they can cause life-threatening problems. The estimated incidence in the general population is three per million, but oral contraceptive (OC) usage in women increases incidence to 3 to 4 per 100,000. 5 With increased exposure to OCs by increasing either the length of time or the dosage, the risk of developing an LCA rises. With the association of estrogen and LCA, occurrence is more common in women than men (11:1), and they are more likely to occur in the reproductive years. 5 LCAs are also associated with clomiphene, methyltestosterone, Klinefelter syndrome, glycogen storage diseases, and familial polyposis. 3 LCAs are generally solitary lesions, although a patient may have two to three of them. If more than 5 to 10 are present, a diagnosis of liver adenomatosis is made, which will be discussed later.
Patients present with symptoms from LCAs 50% to 75% of the time as opposed to FNHs and hemangiomas, which typically present as incidental findings. Symptoms are usually upper abdominal pain due to hemorrhage or compression of adjacent structures. Often symptoms mimic cholecystitis. Sometimes hemorrhage is intraperitoneal, massive, and fatal. The risk of hemorrhage may increase with the size of the LCA (i.e., greater than 4-5 cm) and subcapsular location, although some authors argue that size and location do not predict the likelihood of hemorrhage. LCAs vary in size from millimeters to 30 cm. Hepatomegaly may be the presenting diagnosis. 3 Unlike the normal hepatocytes of FNHs, the hepatocytes in LCAs tend to be larger in size and contain increased lipids and glycogen. Some may have atypia. The lipid content causes the soft light brown to yellow color of HCAs. No portal tracts, bile ducts, or hepatic veins are found in LCAs. 3 The hepatocytes are arranged in sheets, and the associated Kupffer cells are decreased in number or absent. Blood perfusion is from the periphery to the center. LCAs are vascular tumors that have high-pressure feeding arteries and blood-filled sinusoids, but the connective tissue support is poor, so they are prone to hemorrhage. 5, 10 One study found that LCAs have three different genetic types in the hepatocytes: hepatocyte nuclear factor 1, inactivated beta-catenin activated, and inflammatory. Beta-catenin mutations are common to 40% of HCCs as well as LCAs. These mutations may play a factor in the malignant transformation of LCAs. 1 The most accurate imaging modality to diagnose LCAs is MRI. The sonographic presentation is variable due to hemorrhage and necrosis, so they may appear complex and mimic other pathologies. They tend to be echogenic in normal liver parenchyma because of increased fat content. The typical sonographic appearance is an echogenic nodule with clear margins ( Figures  6, 7, 8) . In a fatty liver, they may appear hypoechoic. Multiphase helical CT displays the peripheral enhancement with centripetal contrast enhancement differentiating LCAs from FNHs. MRI best displays the characteristics of LCAs because it demonstrates the hypervascular nature, the perfusion pattern, and the intratumoral fat. LCAs lack portal veins, so contrast washes out in the portal phase. Patients are often followed with MRI as in this reported case study. Sometimes imaging is unable to differentiate LCAs from FNHs and HCCs, so the patient is referred for biopsy. 3 Core biopsy is not recommended for young healthy patients because of the risks of hemorrhage and tumor dissemination. Approximately two-thirds of core biopsies are false negatives for HCC because only a portion of the LCA may harbor malignant cells and they are easily missed. Therefore, to obtain the most accurate diagnosis, surgical excision is necessary. 3 The two major problems with LCAs are the risk of malignant transformation and the risk of hemorrhage. The risk of malignant transformation is about 10%. Even in cases when the woman has stopped using oral contraceptives or hormone therapy and the tumor regresses, HCC may form years later. 3 The risk of hemorrhage within or external to a nodule is 20% to 40%. Most of the hemorrhage is contained within the LCA, but in a study of 79 patients with LCA, six died from hemorrhage. As previously mentioned, size and location are questionable indicators to predict the risk of hemorrhage. During pregnancy and in the puerperium period, hemorrhage has been reported from LCAs; therefore, affected women are advised against pregnancy unless the tumor has been surgically removed. 3 Because of the unpredictable serious risks of LCAs, surgical resection is recommended for single LCAs. Surgical excision is the only cure and the only way to eliminate the risks of HCC and hemorrhage. With liver resection, morbidity is 10% to 27%, and mortality is 0% to 3%. The risks associated with surgery are less than those of hemorrhage and malignant transformation, so surgery is an option. Liver resection is often done after the cessation of oral contraceptives to decrease tumor size and reduce surgical risks. In some cases, embolization of the hepatic artery may be done to promote regression and manage hemorrhage. 3 
Liver Adenomatosis
Liver adenomatosis (LA) is defined by one source as five or more LCAs not associated with a history of glycogen storage disease, oral contraceptive use, or anabolic steroid use. The case presented here has some characteristics of LA because of the innumerable LCAs. About 30 years after Edmondson discovered LCAs while performing autopsies, Flejou defined LA as a separate disorder with 10 or more LCAs without the usual risk factors. 11 LA has a predilection for women, with male to female ratios ranging from 1:7 to 1:15. 10 Populations most affected are the young and middle aged. Ten to twentyfour percent of patients with an LCA have LA. 3 In a study of 94 patients with LA, 43% presented with acute pain caused by hemorrhage. 12 Rarely, presentation may be acute abdomen pain and life-threatening hemorrhage into the peritoneal cavity. 13 Symptoms may mimic those of cholelithiasis, and the tumors are discovered during investigation of the gallbladder. 3 Alkaline phosphatase and serum gamma glutamyltransferase (GGT) are often elevated in LA patients because of the spaceoccupying characteristics of the lesions and may be the presenting sign.
In another study of 15 patients with LA, 4 had LA discovered incidentally, 8 had chronic abdominal pain, 3 had acute abdominal pain, and 10 had hepatomegaly. This series included 1 man and 14 women with a mean age of 36 years (range, 19-66 years) ( Table 1) . 14 In a French study of eight LA patients ranging in age from 14 to 45 years, two were asymptomatic, four presented with abdominal pain, two with hepatomegaly, and two with intraperitoneal bleeding. 13 The youngest patient was age (1) is more echogenic and has decreased signal on magnetic resonance imaging, and the FNH has increased signal density. 13 years, and the oldest was age 75 years. 13 Last, a study of 20 women, ages 19 to 54 years, found that 10 presented with abdominal pain due to hemorrhage and 10 were asymptomatic. 9 Diagnosis is made by a combination of imaging and histology. The sonographic features of LCAs in LA are similar to those seen with single LCAs. Sonography typically underestimates the number of lesions in LA. Multiphase helical CT shows early peripheral contrast enhancement with later central enhancement. This pattern distinguishes LCAs from FNHs. MRI is the most sensitive and the modality of choice for follow-up. 3 MRI is preferred over CT because it provides more information on the number and nature of lesions and is able to exclude angiomas and fatty infiltration or steatosis. 13 Differentiation of LA from HCC is difficult on MRI currently but might be possible in the future as imaging modalities improve. HCCs have portal blood supply, which is absent in LCAs. This may be the key to differentiating them in the future with imaging. Surgical cases indicate that imaging studies underestimate the number of lesions. 14 Percutaneous biopsy, as with single LCAs, is contraindicated in young, fit patients because it may be inaccurate, cannot exclude malignancy, and has a risk of hemorrhage. The preferred method of biopsy is open surgery or laparoscopy. 3 Microscopically, the LCAs in LA are similar to those existing as singles. They are composed of normal or slightly atypical hepatocytes containing increased glycogen or lipid content, making them appear larger and paler than normal tissue. 16 LCAs lack Kupffer cells, bile ducts, and portal vessels. LCA specimens are soft and light brown to yellow. 10, 17 Spontaneous hemorrhage is possible because of the high-pressure blood supply and bloodfilled sinusoids combined with poor soft tissue support. 3 A study of MRI features and pathology of 20 LA patients found three types of LA cell types: steatotic, peliotic, and mixed. Steatotic and peliotic tumors had an average (mean ± SD) diameter of 6.3 ± 1.7 cm. The mixed tumors were larger. All three types had the same tendency to hemorrhage, with a size greater than 4 cm the most likely predictor. 9 The cause of LA is not certain, but two theories exist. The first suggests a genetic cause. A study of two unrelated families in which a family member had LA found germline mutation in hepatocyte nuclear factor 1 alpha (HNF-1 alpha). This germline mutation is also associated with maturity-onset diabetes of the young type 3 (MODY3). Imaging and testing of the two families in which one member had LA uncovered other cases of LA and MODY3. If a family member has either disease, it is recommended that other members be screened. 18 The second theory states that LA is a response to a congenital or acquired vascular abnormality in the liver. This is supported by the coexistence of FNH with LCAs in livers with adenomatosis. Our case study has multiple FNHs, hemangiomas, and innumerable LCAs. In a study of 15 patients with LA, three had a vascular malformation involving the portal vein that was congenitally absent or thrombosed or had portosytemic venous shunts. 14, 17 Along with two theories as to the cause of LA, there are also two types. Multifocal LA tends to be more common in asymptomatic patients. The liver contour is not deformed, and the liver is not enlarged. The tumors are numerous but 4 cm or less. 3 Hepatomegaly and contour deformation are associated with massive type LA. Massive LA has numerous tumors 2 to 10 cm in size and is more aggressive in growth. Because the lesions are larger and growing more rapidly, the risk of hemorrhage is greater than in multifocal patients. Massive LA patients are more likely to be treated surgically. If large tumors are in one lobe of the liver, resection may be therapeutic. 3 LA has LCAs that tend to increase in size and number with time or remain stable. In some, it is a slowly progressive disease, but some cases (massive) tend to grow rapidly. 19, 20 All 15 cases in one series showed an increase in the number or size of the adenomas in a 2-to 12-year follow-up. 14 However, in a larger study of 81 LA patients, 41 had stable disease, and 34 had an increase in size or number of lesions. The risk of hemorrhage is about 46%. Lesions larger than 4 to 5 cm and in a subcapsular location are recommended for resection to prevent bleeding, especially into the peritoneal cavity. In the study of 81 patients with an average follow-up of 57 months, six (7%) developed malignancy. Because four of the six were men, it is postulated that men with LA are at greater risk for HCC than women. 3 Initially, in asymptomatic patients, follow-up with annual MRI, CT, or sonographic imaging is recommended. As previously mentioned, MRI is the most sensitive to characterize the LCAs. Imaging is done to monitor size and changes in the LCAs. Serum AFP should also be checked at regular intervals. 3 One source recommends AFP and sonography every three months. 20 LA has a negative effect on women in their childbearing years. Because of the increased risk of hemorrhage from an LCA during pregnancy and the perinatal period, pregnancy can be dangerous and even life threatening to the mother. Also, because oral contraceptives are associated with the growth of LCAs, they are not recommended to avoid a pregnancy. Although resection can be done in a woman with one or two LCAs in a liver lobe, this is not a possibility when numerous widespread tumors are present. 3 Therefore, LA often is a contraindication for pregnancy and OC use.
Surgical removal of tumors and/or liver resection is indicated for abdominal pain, tumor growth, and tumor bleeding. In a study of eight patients who had surgery for such at the Mayo Clinic, all had a good outcome. 21 Transarterial chemoembolization has been used to treat some tumors with success. 22 For those symptomatic patients who have had resections or are not candidates for resection, liver transplantation is the best option for a cure to avoid the risks of hemorrhage and HCC. However, transplantation has risks, which must be balanced against the risks of LA. Perioperative liver transplantation mortality is 1% or less. The five-year survival rate is approximately 66%, with most deaths occurring in the first six months of transplantation. The eight-year survival rate is close to 61%. Unfortunately, of recipients, 11.5% will develop new liver tumors due to immunosuppression, 10% will develop renal failure, and 5% will develop hypertension. The rejection rate is 3% to 5%. Biliary anastomosis problems develop in 15% to 33%. Three of ten who had a transplant because of LA developed HCC and/or lung metastasis. Only one of these had HCC in the native liver. Thus, liver transplantation does not eliminate the risk of HCC. 3 Because of the condition of LA patients and the shortage of available livers for donation, living donor transplantation is preferred. 20 However, the surgery is major, with risks for both donor and recipient, so it must be seriously considered.
Conclusion
In developed countries, approximately 10% to 20% of people have benign liver tumors, so discovery by medical imaging of "incidentalomas" is commonplace. Liver masses often are of no consequence, as seen with hemangiomas and focal nodular hyperplasia. However, the discovery of liver masses is disconcerting to patients, and some masses such as liver cell adenomas and malignancies have serious consequences, so physicians are obligated to diagnose incidentalomas.
Gray-scale and color Doppler sonography alone are rarely adequate to make a diagnosis because many lesions have a nonspecific appearance. Contrast-enhanced sonography greatly improves the accuracy of sonography. Currently in the United States, a workup consists of sonography, CT, MRI, lab values, and sometimes percutaneous biopsy or excision. LCAs require surgical excision to rule out malignancy because core biopsies can miss HCC present in the lesions. Surgical resection or excision is recommended for single LCAs to prevent malignancy and hemorrhage. LCA incidentalomas can be life threatening and life altering.
Liver adenomatosis, which involves five or more LCAs present in a liver, without the known risk factors for LCAs, is difficult to manage. LA is particularly difficult during childbearing years for women because the use of OCs and pregnancy is not recommended. In many cases, follow-up with MRI and laboratory values is indicated. For cases with hemorrhage and malignancy, live-donor liver transplantation is the most viable option for a cure.
Our case study was diagnosed with a combination of sonography, CT, liver enzyme labs, AFP, and MRI. Follow-up helped confirm the diagnosis over time. Currently she is followed with yearly MRI and blood tests. Perhaps in the future, advances in sonography such as contrast enhancement in the United States will allow follow-up to be shifted from MRI to less costly sonography.
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All images taken on a General Electric Logiq E9 (Milwaukee, Wisconsin) by Anju Tomar. MRI images were taken on a General Electric 1.5 Telsa. Fusion was done by loading the MRI volume of data via CD onto the Logiq E9. A common point was chosen such as the portal vein bifurcation and marked on both the sonographic and MRI images. The GPS sensor was positioned on the left side of the patient, enabling the system to display the sonographic image on the left and the corresponding MRI image on the right in real time. The images can also be superimposed or fused.
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